Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-038030
Filing Date
2024-09-24
Accepted
2024-09-24 21:00:12
Documents
1
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2175
  Complete submission text file 0001493152-24-038030.txt   3575
Mailing Address 303 N. SWALL DRIVE UNIT #102 BEVERLY HILLS CA 90211
Business Address
Murali Ramachandran (Reporting) CIK: 0001870016 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42275 | Film No.: 241321126

Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Issuer) CIK: 0001962011 (see all company filings)

IRS No.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)